Biospecifics Technologies (BSTC US)

Health Care • United States

BioSpecifics Technologies Corp. is a biopharmaceutical company. The Company developed and licensed injectable collagenase for the treatment of Dupuytren's disease, Peyronie's disease, and adhesive capsulitis (frozen shoulder).

Refresh

Focused

No publications yet

There aren’t any podcasts right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00